mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.3 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.3 |
mRNA |
JW-74 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.3 |